A study of the safety of alpha1-blocker silodosin in adult wome
Phase 1
- Conditions
- rination impaired
- Registration Number
- JPRN-UMIN000009102
- Lead Sponsor
- Kinki University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with serious comorbid heart disease. Patient with serious comorbid liver disease or total bilirubin level more than 3 mg/dL or AST(GOT) or ALT(GPT) & 2.5 times the upper limit of the reference range. Patient with serious comorbid kidney disease or serum creatinine & more than 1.5 mg/dL. Patient with serious hypotension. Woman who is pregnant, nursing, wishes to become pregnant during the study period, or cannot follow physician's instructions regarding contraception. Patient who has taken another study drug or investigational drug within 1 month prior to beginning this study. Others judged to be unsuited as subjects according to the Principal Investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method